American Society of Hematology

American Society of Hematology The world's largest professional society concerned with the causes and treatments of blood disorders.

Conheça os critérios para participar do LATP 2027O Latin American Training Program (LATP) 2027 oferece até 12 semanas de...
09/11/2026

Conheça os critérios para participar do LATP 2027
O Latin American Training Program (LATP) 2027 oferece até 12 semanas de treinamento presencial 100% custeados pela ASH.
Os candidatos devem ser hematologistas ou profissionais de saúde relacionados à hematologia que atuem em um hospital, clínica ou laboratório.
Não podem ser fellows, residentes ou estagiários em treinamento.
Os candidatos podem estar em qualquer etapa de suas carreiras e não precisam ser membros da ASH.
Não é necessária proficiência em inglês, pois o treinamento será realizado em espanhol ou português.
São 6 centros de treinamento espalhados pela América Latina.
Saiba mais sobre o LATP

-----------------------------------------------

El Programa de Capacitación Latinoamericano (LATP) 2027 ofrece hasta 12 semanas de capacitación presencial financiadas al 100 % por la ASH.
Los candidatos deben ser hematólogos o profesionales de la salud relacionados con la hematología que trabajen en un hospital, una clínica o un laboratorio.
No pueden ser becarios, residentes ni pasantes en formación.
Los candidatos pueden encontrarse en cualquier etapa de su carrera y no es necesario que sean miembros de la ASH.
No se requiere dominio del inglés, ya que la capacitación se llevará a cabo en español o portugués.
Hay 6 centros de capacitación repartidos por toda América Latina.
Obtén más información sobre el LATP
Programa de Capacitación Latinoamericano de la ASH - https://ow.ly/kTb650ZMKmi

ASH led more than 50 organizations representing patients, health care providers, researchers, and public health professi...
09/11/2026

ASH led more than 50 organizations representing patients, health care providers, researchers, and public health professionals in sending a letter to CDC Director, Dr. Erica Schwartz urging the agency to restore the Division of Blood Disorders & Public Health Genomics (DBDPHG) to full operational capacity.

The letter highlights the Division’s critical role in supporting surveillance, data collection, laboratory services, and public health programs for people living with sickle cell disease, hemophilia, thalassemia, blood clots, and other blood disorders.

The blood disorders community stands ready to work with CDC to strengthen these essential programs and improve outcomes for patients and communities nationwide.

Read the full letter: https://ow.ly/qK3t50ZMxxi

This , the ASH Foundation is raising $10K for the Sickle Cell Disease Initiative Fund to support SCD research, educatio...
09/10/2026

This , the ASH Foundation is raising $10K for the Sickle Cell Disease Initiative Fund to support SCD research, education, and care. 🩸

Make a gift today: https://ow.ly/RmE750ZLCNn

Meet 2026 ASH Treating Fairly Research Award recipients whose work addresses important needs for people living with sick...
09/08/2026

Meet 2026 ASH Treating Fairly Research Award recipients whose work addresses important needs for people living with sickle cell disease. 🩸

Susan Creary, MD, MSc, is developing a tool to better support men living with SCD in fertility and reproductive planning, while Charity Oyedeji, MD, is working to improve how physical function is assessed in people with SCD as they age.

During Sickle Cell Awareness Month, ASH is proud to spotlight their research and its potential to improve care and quality of life for people living with SCD.

Help support the future of sickle cell disease research and care by donating to the ASH Foundation’s Sickle Cell Disease Initiative Fund: https://ow.ly/4sHV50ZJCQU

ASH is now accepting applications for the 2027 Treating Fairly Research Award. Apply Today and get support to advance your research in Sickle Cell Disease. https://ow.ly/W9Eu50ZJCQW

ASH-a-Palooza is where trainees come together at to discover career opportunities, build meaningful connections, and g...
09/07/2026

ASH-a-Palooza is where trainees come together at to discover career opportunities, build meaningful connections, and gain practical insights for the future of hematology.

From one-on-one mentoring with Blood Buddies and TED-style ASH Talks to career-focused Blood Drops and interactive Blood Booths, there's something for every stage of the trainee journey.

Learn from leaders. Connect with mentors. Explore what's next.

Register today: https://ow.ly/nEAa50ZJKQY

Personaliza tu capacitación internacionalEl Programa de Capacitación para Visitantes (VTP) 2027 te permite desarrollar u...
09/04/2026

Personaliza tu capacitación internacional
El Programa de Capacitación para Visitantes (VTP) 2027 te permite desarrollar un plan de capacitación a la medida, alineado con tus metas profesionales.
Con el apoyo de un mentor miembro de la ASH, podrás estructurar una experiencia de aprendizaje de gran impacto.
✔️ Fechas flexibles
✔️ Costos totalmente cubiertos por la ASH
Inscripciones abiertas hasta el 5 de octubre de 2026.
Conoce el VTP
Programa de Capacitación para Visitantes de la ASH - https://ow.ly/aoti50ZJCBt

______

Personalize seu treinamento internacional
O Visitor Training Program (VTP) 2027 permite que você desenvolva um plano de treinamento sob medida, alinhado às suas metas profissionais.
Com o acompanhamento de um mentor membro da ASH, você poderá estruturar uma experiência de aprendizado de alto impacto.
✔️ Datas flexíveis
✔️ Custos totalmente cobertos pela ASH
Inscrições abertas até 5 de outubro de 2026.
[botão] Conheça o VTP
ASH Visitor Training Program - https://ow.ly/aoti50ZJCBt

Choosing an initial treatment for immune thrombocytopenia (ITP) is a shared decision. ASH's new shared decision-making t...
09/03/2026

Choosing an initial treatment for immune thrombocytopenia (ITP) is a shared decision. ASH's new shared decision-making tool helps guide conversations between clinicians and patients as they discuss initial therapy options.

Learn more: https://ow.ly/5LJ550ZIsaW

Advances in the treatment of major blood cancers have saved more than 25 million years of life in the United States over...
09/02/2026

Advances in the treatment of major blood cancers have saved more than 25 million years of life in the United States over the past 75 years. But gains have not reached everyone equally, and instability in research funding puts continued progress at risk.

In a new analysis, E. Anders Kolb, MD, and colleagues from Blood Cancer United found that survival progress remains limited for people diagnosed with acute myeloid leukemia and across most major blood cancer types among Black individuals.

Read about this new Blood Advances study: https://ow.ly/QPoc50ZIgwc

September is National Sickle Cell Awareness Month. Throughout the month, ASH will highlight the people, programs, partne...
09/01/2026

September is National Sickle Cell Awareness Month. Throughout the month, ASH will highlight the people, programs, partnerships, and progress helping advance Sickle Cell Disease (SCD) research and care.

Bringing the SCD community together is an important part of that effort. The Sickle Cell Disease Coalition creates opportunities for people living with SCD, caregivers, advocates, clinicians, researchers, and organizations to connect and collaborate through:

◼️ SCD Unified Action Forum — aligning around shared priorities
◼️ Annual Summit — advancing whole-person SCD care
◼️ Peer Learning Exchanges — sharing knowledge and building skills

This September, the ASH Foundation is also working to raise $10,000 to support sickle cell disease initiatives. Every contribution helps advance research, care, and resources for people living with SCD.

Help reach the $10,000 goal. Donate to the ASH Sickle Cell Disease Initiative Fund today: https://ow.ly/kMNh50ZGHKp

The future of hematology research is at risk.A proposed rule from the Office of Management and Budget (OMB) would dramat...
08/31/2026

The future of hematology research is at risk.

A proposed rule from the Office of Management and Budget (OMB) would dramatically reshape the federal grantmaking process by allowing agencies to terminate grants, override scientific peer review recommendations, and limit scientific dissemination. These changes could delay discoveries, disrupt clinical trials, and threaten advances in blood cancer, leukemia, sickle cell disease, stem cell transplantation, and other areas of hematology research.

The Senate has already passed language that would delay implementation of this rule, but the House must act before the rule is scheduled to take effect.

📢 Now is the time to speak up. Contact your House Representative and urge them to support delaying implementation of this harmful rule and work toward a permanent solution to rescind it.

https://ow.ly/WSU550ZHmKM

Address

2021 L Street NW, Suite 900
Washington D.C., DC
20036

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+12027760544

Website

Alerts

Be the first to know and let us send you an email when American Society of Hematology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share